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Abstract
Background  and  objectives:  Satellite  glial  cells  in  sensory  ganglia  are  a  recent  subject  of
research in  the  ﬁeld  of  pain  and  a  possible  therapeutic  target  in  the  future.  Therefore,  the
aim  of  this  study  was  to  summarize  some  of  the  important  physiological  and  morphological
characteristics of  these  cells  and  gather  the  most  relevant  scientiﬁc  evidence  about  its  possible
role  in  the  development  of  chronic  pain.
Content:  In  the  sensory  ganglia,  each  neuronal  body  is  surrounded  by  satellite  glial  cells  form-
ing  distinct  functional  units.  This  close  relationship  enables  bidirectional  communication  via
a  paracrine  signaling  between  those  two  cell  types.  There  is  a  growing  body  of  evidence  that
glial  satellite  cells  undergo  structural  and  biochemical  changes  after  nerve  injury,  which  inﬂu-
ence  neuronal  excitability  and  consequently  the  development  and/or  maintenance  of  pain  in
different  animal  models  of  chronic  pain.
Conclusions:  Satellite  glial  cells  are  important  in  the  establishment  of  physiological  pain,  in
addition to  being  a  potential  target  for  the  development  of  new  pain  treatments.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Células  gliais  satélite;
Gânglio sensitivo;
Dor;
Células  gliais  satélite  de  gânglios  sensitivos:  o  seu  papel  na  dor
Resumo
Justiﬁcativa  e  objetivos:  As  células  gliais  satélite  de  gânglios  sensitivos  são  um  objeto  recente
de pesquisa  na  área  da  dor  e  um  possível  alvo  terapêutico  no  futuro.  Assim,  este  trabalho  tem
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Comunicac¸ão
intraganglionar;
Receptores
purinérgicos
como  objetivo  resumir  algumas  das  características  morfológicas  e  ﬁsiológicas  mais  importantes
destas  células  e  reunir  as  evidências  cientíﬁcas  mais  relevantes  acerca  do  seu  possível  papel  no
desenvolvimento  da  dor  crônica.
Conteúdo:  Nos  gânglios  sensitivos  cada  corpo  neuronial  é  envolvido  por  células  gliais  satélite,
formando unidades  funcionais  distintas.  Esta  íntima  relac¸ão  possibilita  a  comunicac¸ão  bidire-
cional,  através  de  uma  sinalizac¸ão  parácrina,  entre  estes  dois  tipos  de  células.  Existe  um  número
crescente  de  evidências  de  que  as  células  gliais  satélite  sofrem  alterac¸ões  estruturais  e  bio-
químicas,  após  lesão  nervosa,  que  inﬂuenciam  a  excitabilidade  neuronial  e  consequentemente
o desenvolvimento  e/ou  manutenc¸ão  da  dor,  em  diferentes  modelos  animais  de  dor  crônica.
Conclusões:  As  células  gliais  satélite  são  importantes  no  estabelecimento  da  dor  não  ﬁsiológica
e constituem  um  alvo  potencial  para  o  desenvolvimento  de  novos  tratamentos  da  dor.
©  2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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ain  has  a  physiological  protective  role  acting  as  a war-
ing signal  to  any  threat  to  the  physical  integrity  of  the
ody, but  it  can  become  a  disease  in  itself  when  it  persists
nd recurs  for  more  than  three  months,  becoming  chronic
nd devoid  of  any  biological  function.1 It  is  a  perceptive,
omplex, subjective,  and  multidimensional  phenomenon.
ifferent forms  of  pain  are  produced  by  multiple  molecu-
ar and  cellular  mechanisms  acting  alone  or  in  combination
ith the  central  and  peripheral  nervous  systems.2 In  search
f new  therapeutic  targets  it  is  essential  to  understand  the
echanisms responsible  for  the  generation  and  maintenance
f pain  and  identify  the  cells  and/or  molecules  involved.3 In
his context,  the  glial  cells  of  the  central  nervous  system
CNS), and  more  recently  those  of  the  sensory  ganglia,  have
hown to  be  important  in  these  mechanisms,  as  they  have
he ability  to  communicate  with  neurons  and  modulate  its
ctivity.4,5 In  sensory  ganglia,  particularly  in  dorsal  spinal
anglia (DSG)  and  trigeminal  ganglion  (TG),  satellite  glial
ells (SGC)  establish  a  privileged  relationship  with  the  sur-
ounding neuronal  bodies.6 Interactions  between  SGC  and
eurons and  its  consequences  on  neuronal  excitability  are
ne of  the  most  recent  research  focuses  on  the  ﬁeld  of
ain, as  in  the  last  ten  years  the  number  of  articles  on  the
ole these  cells  play  in  neuronal  activity  has  increased  sig-
iﬁcantly. Therefore,  the  aim  of  this  study  was  to  gather
nowledge about  the  morphological  and  functional  charac-
eristics of  SGC  and  its  interaction  with  the  primary  afferent
eurons. We  also  reviewed  the  available  information  on  the
hanges seen  in  these  cells  in  different  models  for  the  study
f pain  in  animals  and  its  impact  on  neuronal  activity  and
onsequently in  chronic  pain.
he SGChe  SGC,  as  well  as  the  Schwann  cells,  are  derived  from
he pluripotent  neural  crest  cells.7 Morphologically,  these
ells are  characterized  by  a  laminar,  irregular  shape,  usually
I
a
r
fononuclear,  with  lamellar  expansions  and  microvilli  that
ncrease its  surface  area.8--10 These  cells  surround  each  neu-
on and  the  proximal  portion  of  its  axon,  forming  a  sheath
round each  cell  body.  Each  cell  body  surrounded  by  a  sheath
f SGC  forms  a morphologically  and  functionally  distinct
nit.6,11 The  SGC  from  a  sheath  are  connected  together  by
dhesive and  gap  junctions,  and  are  separated  from  the
eighboring perineuronal  sheath  by  connective  tissue.12--14
hysiologically,  SGC  are  regarded  as  the  equivalent  cells
n the  peripheral  nervous  system  to  the  CNS  astrocytes,
ith the  investigation  of  its  features  marked  by  this  anal-
gy. Properties  such  as  regulation  of  ion  concentration  of
xtracellular space  and  the  recycling  of  neurotransmitters
re shared  with  them.  They  are  molecular  markers  of  glu-
amine synthase  (GS),  proteins  of  the  S100  family  involved
n the  regulation  of  intracellular  calcium  and  expression
f glial  ﬁbrillary  acidic  protein  (GFAP).6 Electrophysio-
ogically, glial  cells  exhibit  a  highly  negative  membrane
otential at  rest  and  express  voltage-dependent  calcium  and
otassium channels  Kir4.1.15--17 They  also  express  numer-
us receptors  of  bioactive  molecules,  potentially  involved
n interactions  with  other  cells,  with  many  of  them  recently
mplicated in  the  genesis  and  maintenance  of  chronic
ain, namely,  the  P2Y18,19 and  P2X720 purinergic,  calcitonin
ene-related peptide  (CGRP),21 substance  P,22 and  cytokine
nd chemokine  receptors----examples  of  which  are  tumor
ecrosis factor  alpha  (TNF)23 and  interleukin-1  beta  (IL-
)24 and  endothelin-B25 and  N-methyl-d-aspartate  (NMDAr)
eceptors.26
ntraganglionar communication
nitially,  the  main  function  assigned  to  the  cell  body  of
he afferent  neurons  was  the  metabolic  support,  ensuring
he maintenance  of  optimal  levels  of  ion  channels,  recep-
ors, and  proteins  in  the  central  and  peripheral  terminals.
n recent  decades,  increasing  evidence  of  morphological
nd physiological  properties  deﬁnitely  put  aside  the  passive
ole assigned  to  the  cell  body  in  the  path  of  information
rom the  periphery  to  the  CNS.  One  of  the  morphological
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Figure  1  Intraganglionar  communication.  After  peripheral
nerve injury  a  somatic  neurotransmitter  release  occurs,  such  as
the calcitonin  gene-related  peptide  (CGRP),  substance  P,  adeno-
sine triphosphate  (ATP),  and  nitric  oxide  (NO)  in  perineuronal
environment. These  mediators  activate  satellite  glial  cells  via
their receptors  located  on  the  surface  membrane  of  cells.  This
activation leads  to  release  of  cytokines  such  as  tumor  necrosis
factor alpha  (TNF)  and  interleukin  1  beta  (IL-1),  which  in  turn
can inﬂuence  neuronal  excitability  through  speciﬁc  receptors
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peculiarities  encountered  is  the  presence  of  several  neu-
rotransmitter receptors  in  the  cell  body,  although  there  is
virtually no  contact  in  synaptic  ganglion.27 Electrophysio-
logical studies  in  vivo  have  found  other  indicators  showing
that the  excitation  of  DSG  neurons  led  to  the  develop-
ment of  action  potential  in  neighboring  neurons,  a  property
called cross-excitation.  This  potential  was  conﬁrmed  in
studies in  vitro  in  which  repeated  stimulation  of  these
neurons induced  a  transient  depolarization  of  neighboring
neurons in  this  ganglion,  probably  mediated  by  chemical
messengers.28,29 According  to  this  assumption,  it  was  found
that in  response  to  an  electrical  or  chemical  stimulation
there is  a  calcium-dependent  somatic  release30 of  dif-
fusible chemical  mediators  capable  of  altering  the  somatic
excitability in  sensory  ganglia.  Examples  of  such  mediators
are substance  P,  adenosine  triphosphate  (ATP),  gamma-
amino-butyric acid  (GABA),  CGRP,  and  glutamate.20,21,30--34
On  the  other  hand,  the  cellular  body  is  completely
enveloped by  the  GSC  sheath,  suggesting  that  the  effect  of
these mediators  on  surrounding  neurons  is  indirect,  involv-
ing the  SGC.34 The  SGC  peculiar  arrangement  in  sensory
ganglia guarantees  an  intimate  association  of  the  neuronal
body with  the  SGC,  allowing  these  glial  cells  to  control  the
perineural environment  and  facilitate  non-synaptic  commu-
nication between  these  two  cell  types.21,22,34,35 Indeed,  the
existence of  two-way  interactions  between  sensory  neu-
rons and  SGC  was  recently  demonstrated.34,35 The  way
the CGS-neuron  communication  takes  place,  the  actors  in
the process,  and  its  impact  on  the  modulation  of  afferent
information are  far  from  being  understood.  However,  some
potential candidate  to  mediate  this  paracrine  signaling  are
substance P,  CGRP,  cytokines,  endothelins,  nitric  oxide  (NO),
and ATP22 (Fig.  1).
ATP  seems  to  be  the  main  mediator  in  the  interaction
between neurons  and  SGC34,35 in  sensory  ganglia.  P2  recep-
tors are  expressed  in  sensory  neurons  (all  P2X,  except  P2X7R
and P2YR  1,  2,  4,  6),  Schwann  cells,  and  SGC  (for  review
see).36 Through  calcium  imaging,  the  presence  of  functional
P2Y receptors  was  detected  in  GSC  of  intact  TG  of  rodents.37
This  expression  was  conﬁrmed  in  studies  with  cultured  TG
cells, and  the  receptors  were  classiﬁed  as  P2Y  1,  2,  4  6,
12 and  13  subtypes.18,19 In  DSG,  only  the  level  of  mRNA
was assessed.38 Among  the  ionotropic  receptors,  P2X4 and
P2X739,40 subtypes  are  found  in  the  SGC,  but  recent  stud-
ies have  reported  the  possibility  that  they  also  express  P2X2
and  P2X5 receptors.41 The  differential  expression  of  P2X7 and
P2X3 receptors  in  SGC  and  neurons,  respectively,  provided  a
way to  distinguish  the  actions  of  ATP  in  neurons  and  SGC.39,40
It  was  found  that  blocking  the  activation  of  the  P2X7 recep-
tor with  an  antagonist  or  reducing  its  expression  using  RNA
interference (RNAi)  in  normal  rodents,  there  is  an  increased
neuronal expression  of  P2X3,  suggesting  that  the  tonic  acti-
vation of  the  SGC  P2X7 receptors  exerts  an  inhibiting  control
over the  P2X3.  On  the  other  hand,  the  ATP  released  by  neu-
rons can  activate  the  P2X7 receptor  of  the  SGC  leading  to
the release  of  cytokines,  namely  TNF-,  which  enhances
the neuron  P2X3 receptor  mediated  response.  Thus,  it  was
concluded that  the  P2X7 exerts  inﬂuence,  either  excitatory
or inhibitory,  on  the  sensory  neuron  soma.20,40 It  was  also
shown that  the  vesicular  release  of  ATP  by  the  cell  body  of
neurons in  the  DSG  acts  on  the  P2X7  receptor  by  increasing
the intracellular  concentration  of  Ca2+ in  the  surrounding
s
w
o
nTNF-RI and  IL-1RI).  Adapted  with  permission  Ref. 22.
GC.  This  ﬁnding  is  relevant  because  the  waves  of  Ca2+ are
sed as  a  mechanism  of  information  transmission  network
mong astrocytes,  mediated  by  ATP  and  gap  junctions.42
hus,  given  that  SGC  express  P2  receptors  and  are  connected
y gap  junctions,  it  was  possible  to  conclude  that  these  cells,
imilar to  astrocytes,  would  also  have  the  ability  to  sustain
alcium waves.  In  this  sense,  a  study  was  conducted  in  pri-
ary cultures  of  TG  and  it  was  found  that  the  electrical  or
echanical stimulation  of  a  single  cell  body  promoted  an
ncrease in  intracellular  calcium  in  neurons  and  surrounding
GC by  a  propagation  similar  to  the  Ca2+ waves.  This  prop-
gation was  essentially  mediated  by  P2  receptors  and,  to  a
esser extent,  by  the  gap  junctions,  which  demonstrated  the
xistence of  a  bidirectional  communication  between  neu-
ons and  SGC  performed  by  Ca2+.35
As  for  substance  P,  the  ﬁnding  of  its  increased  somatic
elease after  orofacial  inﬂammation  was  the  ﬁrst  indica-
ion that  this  substance  plays  an  important  role  in  paracrine
ignaling established  in  ganglia  after  inﬂammation.31,43 This
as later  conﬁrmed  after  ﬁnding  that  the  increased  release
f substance  P  by  A  and  C  nociceptors  was  accompa-
ied by  an  increased  expression  of  NK1  receptors  in  A
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on-nociceptive  surrounding  neurons.44,45 Moreover,  it  has
een suggested  that  this  neuropeptide  can  activate  the  SGC
hrough  NK1  receptors,  so  that  SGC  respond  with  the  syn-
hesis and  release  of  IL1-.22 The  NK1  expression  in  SGC
as not  directly  measured,  but  the  NK1expression  with  high
fﬁnity for  substance  P  has  been  shown  in  astrocytes  and
icroglia.46
The  ﬁnding  that  intraganglionar  release  of  CGRP  occurs
fter activation  of  trigeminal  afferent  neurons,  along  with
he CGRP1  receptor  expression  in  neurons  and  DSG,21 made
his neuropeptide  a  candidate  for  mediating  the  neuron--SGC
nteraction. This  hypothesis  was  reinforced  by  TG  studies,
hich have  shown  that  CGRP  can  act  in  an  autocrine  manner,
timulating the  promoter  activity  of  CGRP  and  increasing
RNA levels.47 Furthermore,  it  may  also  have  a  paracrine
ction on  CGS,  regulating  the  release  of  cytokines  and
hemokines48 and  increasing  the  expression  of  inducible
itric oxide  synthase  (iNOS),  as  well  as  the  release  of
O.21 Nitric  oxide  is  also  a  potential  messenger  between
eurons and  SGC,  as  NO  released  by  neurons  after  nerve
njury acts  on  SGC  causing  increased  expression  of  guany-
ate cyclase  1,  which  catalyzes  the  formation  of  cyclic
uanosine monophosphate.49 Recently,  the  extreme  sensitiv-
ty of  the  TG  SGC  to  endothelin-1  by  ET-B  receptor  activation
as also  demonstrated.50 Because  sensory  neurons  express
ndothelin-1 mRNA,  this  peptide  may  also  be  one  of  the
ctors in  the  communication  between  SGC  and  the  neuron.51
The  functional  expression  of  NMDAr  in  SGC,  whose  activ-
ty may  also  modulate  the  SGC--neuron  interaction  in  DSG,26
as  also  veriﬁed  recently.  Several  facts  indicate  the  occur-
ence of  glutamate  release  in  ganglion,  particularly  the
resence of  glutamate  receptors52 and  vesicular  glutamate
ransporters in  the  neuronal  body.53 Besides  this  evidence,
ll proteins  necessary  for  the  uptake  and  recycling  of  glu-
amate were  found  in  the  SGC,  including  the  glutamate
spartate transporter  (GLAST)  and  glial  glutamate  recycling
nzymes, such  as  GS.6,54 In  a  study  that  sought  to  understand
he role  of  glutamate  in  trigeminal  ganglia,  it  was  found
hat blocking  the  synthesis  of  SG  in  SGC  leads  to  reduced
ctivation threshold  for  mechanical  stimulation  of  the  face.
upposedly, this  effect  is  associated  with  decreased  release
f glutamine  by  SGC  and  hence  to  a  decrease  in  glutamine
vailable for  uptake  by  the  neuron  to  produce  glutamate.55
GC response to nerve injury and effect on
ociception
he  studies  evaluating  the  role  of  sensory  ganglia  in  chronic
ain were  focused  on  changes  in  sensory  neurons  after  nerve
njury. Changes  in  intrinsic  properties  of  the  pericardium
ay lead  to  hyperexcitability,  characterized  by  increased
ncidence of  spontaneous  activity  and  reduced  activation
hreshold by  peripheral  stimuli,  which  result  in  hyperalgesia
nd allodynia  phenomena  seen  after  injury.56,57 Research
n an  animal  model  of  pain,  mostly  performed  in  rodents
nd based  primarily  on  peripheral  lesions  due  to  axotomy,
nﬂammation or  constriction,  indicates  that  nerve  injury
ot only  induces  changes  in  neurons  but  also  in  sensory
anglia SGC.  Similar  to  the  CNS  glial  cells,  the  SGC  are
ctivated under  these  conditions.  The  concept  of  activa-
ion is  based  on  the  notion  that,  under  normal  conditions,
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lial  cells  are  spectators  of  the  nociceptive  process,  but
fter peripheral  injury,  they  react  exhibiting  morphological
hanges and  releasing  glial  mediators.4 Because  neurons  are
he lesion  target,  the  changes  seen  in  SGC  are  secondary  to
euronal changes  and  involve  activation  of  signaling  mech-
nisms between  neurons  and  these  cells.
The  event  that  triggers  these  changes  seem  to  be  related
o increased  neuronal  ﬁring  induced  by  nerve  injury.58 This
ypothesis is  based  on  several  assumptions.  First,  experi-
ents with  various  pain  models  and  methods  of  blocking
euronal activity  demonstrated  that  the  blockade  of  sponta-
eous activity  prevents  the  development  of  pain  associated
ith non-physiological  behavior.  One  of  the  studies  that
stablish this  relationship  used  two  different  pain  models
n rodents:  one  induced  by  chronic  constriction  injury  of
he sciatic  nerve  and  another  induced  by  axotomy  and  liga-
ion of  tibial  and  common  ﬁbular  nerves.  The  effect  of  two
ction potential  blockers  (tetrodotoxin  and  bupivacaine)
as tested  in  these  animals,  administered  alone,  in  normal
nd injured  mice.  Behavioral  tests  for  thermal  hyperalgesia
nd mechanical  allodynia  in  these  same  animals  showed
 reduction  in  the  behavioral  signs  of  pain.  In  the  same
tudy, these  blockers  application  prevented  the  spontaneous
ctivity in  the  injured  sciatic  nerve,  assessed  by  electrophys-
ology after  the  administration  of  blockers,  before  and  after
he animals  were  subjected  to  nerve  injury.59 The  second
ssumption is  based  on  the  observation  that  the  activation  of
GC from  DSG  after  sciatic  nerve  injury  is  prevented  by  the
ocal nerve  conduction  blockade.  In  this  study,  performed  in
 model  of  L4  spinal  nerve  axotomy,  with  an  implanted  infu-
ion pump  of  tetrodotoxin,  there  was  a  marked  reduction  in
he SGC  activation,  when  detected  by  the  assessment  of  the
FAP levels  of  expression  using  immunohistochemistry.  In
hat same  study,  this  result  was  conﬁrmed  by  local  applica-
ion of  other  sodium  channel  blockers  (bupivacaine)  in  rats
ith peripheral  injury  induced  by  the  binding  of  the  ﬁbular
nd tibial  nerves.60
Despite  this  evidence,  the  abnormal  spontaneous  neu-
onal activity  is  only  one  candidate  for  a  triggering  event.  In
act, this  issue  is  a  topic  of  recent  research,  and  there  are
till no  studies  clarifying  the  mechanisms  responsible  for  the
GC activation.  However,  several  studies  have  shown  that
hese cells  undergo  deep  changes  in  response  to  nerve  injury,
ainly characterized  by  an  increased  expression  of  GFAP,
ecreased expression  and  sensitivity  of  potassium  chan-
els, increased  SGC  coupling  by  gap  junctions,  increased
ensitivity to  ATP,  altered  expression  of  purinergic  recep-
ors, and  release  of  ATP  and  cytokines.6,22,54,61 There  is
lso evidence  that  these  changes  may  contribute  to  chronic
ain.62,63
ncreased expression of  GFAP
nder  normal  conditions  the  SGC  exhibit  low,  almost  unde-
ectable, levels  of  GFAP  by  immunohistochemistry,  by  which
he observation  in  several  studies  of  its  increased  expression
fter injury  made  it  the  essential  marker  in  the  assess-
ent of  SGC  activation.16,60,62,64--68 The  signiﬁcance  of  this
ncreased expression  remains  unclear.  Regarding  astrocytes,
ne of  the  explanations  given  relates  this  protein  increase
ith the  communication  between  astrocytes  and  neurons
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via  glutamate.  According  to  this  hypothesis,  the  extracel-
lular increase  of  this  neurotransmitter  would  trigger  the
GFAP increase  required  to  support  the  increased  expres-
sion of  GLAST,  since  this  ﬁlament  is  essential  to  anchor
GLAST to  the  plasma  membrane  of  astrocytes.69,70 Based
on these  ﬁndings,  it  was  hypothesized  that,  as  in  astro-
cytes, the  glutamate  released  in  sensory  ganglia  could
trigger the  increased  expression  of  GFAP  in  SGC,  but  so
far this  has  not  been  proven.54 Even  so,  the  expression  of
GFAP is  considered  the  best  known  marker  of  SGC  acti-
vation. Its  usefulness  could  be  proven  in  a  study  that
used a  model  of  neuropathic  pain  induced  by  ligation  of
the ﬁfth  lumbar  spinal  nerve,  in  which  the  GFAP  reac-
tivity to  assess  the  SGC  activation  was  analyzed.  It  was
demonstrated that  this  activation  contributes  to  the  main-
tenance of  the  neuropathic  pain  symptoms  in  the  early
period of  disease,  more  precisely  the  onset  of  mechanical
allodynia.58
Increased expression and sensitivity of
potassium  channels
SGC  are  responsible  for  perineural  K+ homeostasis  regu-
lated through  the  input  channels  of  rectiﬁed  K+ currents’
glial cell-speciﬁc  (Kir4.1)15,16,71 and  gap  junctions.52,72 The
conventional model  of  neuronal  ionic  balance  predicts
that increased  K+ levels  correspond  to  increased  neu-
ron excitability,  which  can  lead  to  changes  in  sensory
perception.73 Thus,  maintenance  of  low  extracellular  K+
concentrations,  mediated  by  SGC,  may  be  crucial  to  control
the resting  membrane  potential  and  neuronal  excitability.15
To  help  answer  this  question,  several  studies  have  eval-
uated if  the  SGC  response  to  nerve  injury  would  involve
changes in  Kir  channels.  Thus,  the  decreased  expression  of
Kir4.1 was  observed  in  SGC  of  TG,  in  a  model  of  chronic
constriction of  the  infraorbital  nerve.15,74 Also,  in  vitro  elec-
trophysiological studies  of  DRG  from  animals  subjected  to
chronic compression  of  these  ganglia,  it  was  found  that
the SGC  in  injured  ganglia  exhibited  a  signiﬁcant  reduction
of currents  mediated  by  Kir.16 Similar  results  were  found
when the  effect  of  peripheral  inﬂammation  (facial  skin)  on
currents mediated  by  Kir  in  rats  in  vivo  was  investigated
by immunohistochemistry  and  patch  clamp.  In  this  study
there was  a  signiﬁcantly  smaller  increase  of  the  currents
mediated by  Kir  in  rats  with  inﬂammation,  compared  to
naive mice,  followed  by  a  decrease  in  the  activation  thresh-
old to  mechanical  stimuli,  suggestive  of  hyperalgesia.75 The
aforementioned studies  showed  that  the  SGC  response  to
different types  of  injury  includes  the  decreased  expres-
sion of  the  Kir  channels  and  decreased  rectifying  currents
mediated by  them.  On  the  other  hand,  in  the  absence  of
injury, decreased  expression  of  Kir  channels  has  an  impact
on neuronal  activity,  as  shown  by  the  speciﬁc  silencing  of
Kir4.1 expression  using  RNAi.  This  silencing  was  sufﬁcient
to produce  behavioral  signs  of  pain  in  mice,  characterized
by the  development  of  spontaneous  (measured  by  increased
frequency of  closing  the  eyes)  and  evoked  pain  (facial  allo-
dynia), which  reinforced  the  importance  of  SGC  in  the
clearance of  K+ and  its  ability  to  promote  changes  in  neu-
ronal activity.74
a
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ncreased coupling between SGC via gap
unctions
he  bridging  connection  between  SGC  distinct  units  and  the
ncreased number  of  gap  junctions  between  them  were  the
rst evidence  that  SGC  change  in  response  to  peripheral
erve injury.12,13 Subsequently,  studies  of  electrophysiology
nd dye  injection  conﬁrmed  this  increased  coupling  after
 nerve  injury.15,76 Indeed,  the  increased  density  (number)
f gap  junctions  and  coupling  between  sensory  ganglia  SGC
fter  nerve  injury  are  a  consistent  ﬁnding  in  several  studies
f pain.  In  SGC  of  DSG,  this  change  was  found  in  several
odels of  pain,  from  colon63,76 and  thigh71 inﬂammation
o sciatic  nerve  neuritis72 and  DSG  chronic  compression.17
G  studies  also  showed  increased  coupling  between  SGC
n models  of  orofacial  pain,  particularly  after  infraorbital
erve axotomy15 or  chronic  constriction.16 In  order  to  assess
he signiﬁcance  of  this  increase  in  the  coupling  between
he SGC,  found  in  many  models  of  chronic  pain,  a  potent
ap junction  blocker  (carbenoxolone)  was  used,  which  sup-
ressed the  increased  coupling  between  the  SGC  caused  by
n inﬂammation  previously  induced  by  injection  of  com-
lete Freund’s  adjuvant  in  the  thigh,  with  an  increase
n the  threshold  of  activation  stimuli.71 Similar  analgesic
ffects were  seen  with  other  gap  junction  blockers,  such
s meclofenamic  and  palmitoleic  acids,  which  favors  the
ypothesis that  gap  junctions  between  SGC  play  an  impor-
ant role  in  neuronal  excitability.63
The  identiﬁcation  of  a  constituent  molecule  of  gap
unctions, particularly  connexin  43  (Cx43),  allowed  a  dif-
erent experimental  approach  to  study  the  role  of  these
unctions in  SGC.  Thus,  it  was  found  that  after  the  infraor-
ital nerve  injury,  an  increased  expression  of  connexin  also
ccurs.16,55,62 Using  RNAi  for  Cx43  to  change  the  gap  junction
roperties, it  was  observed  that  a  disturbance  in  this  pro-
ein expression  is  enough  to  cause  changes  in  the  activation
hreshold of  afferent  neurons.16 Furthermore,  the  inhibition
f Cx43  expression  in  TG  of  mice  with  orofacial  neuropathic
ain induced  by  chronic  constriction  of  the  infraorbital  nerve
as accompanied  by  a  decreased  behavior  of  spontaneous
nd evoked  pain.62 On  the  other  hand,  when  the  inhibition
as carried  out  in  the  trigeminal  ganglia  of  naive  mice,
 nociceptive  response  identical  to  that  seen  after  nerve
amage has  occurred.16,62 These  studies  suggest  that  inhi-
ition of  Cx43  can  have  pro-nociceptive  or  antinociceptive
ffect in  normal  animals  after  nerve  injury.  In  trigeminal
anglia, some  studies  have  found  increased  expression  of
ther types  of  connexins,  namely  Cx36  and  Cx40,  after
emporomandibular joint  inﬂammation,  suggesting  that  the
ype of  connexin  whose  expression  increases  depends  on  the
ain model  in  question.73 Regardless  of  the  approach,  evi-
ence indicates  that  the  coupling  between  the  SGC,  which
nvolves gap  junctions  and  consequently  Cx43,  appears  to
e associated  with  the  neuropathic  pain  development  and
aintenance. The  underlying  mechanisms  are  still  unknown,
ut several  hypotheses  have  been  identiﬁed,  namely  the  role
f this  coupling  in  maintaining  the  electrochemical  gradient
nd buffering  of  K+ to  allow  the  rapid  redistribution  of  K+fter  nerve  injury.15 Other  hypotheses  suggest  that  this  cou-
ling may  contribute  to  the  sensitization  of  nociceptors  by
ncreasing the  diffusion  of  inﬂammatory  mediators  and/or
7 F.A.L.  Costa,  F.L.  Moreira  Neto
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Figure  2  Model  of  interaction  between  neurons  via  satellite
glial cells.  Peripheral  nerve  injury  leads  to  release  of  somatic
ATP that  acts  via  purinergic  receptors  on  satellite  glial  cells
(SGC), leading  to  a  signiﬁcant  increase  in  intracellular  calcium
concentration ([Ca2+])  in  these  cells.  The  communication  with
satellite glial  cells  of  neighboring  perineural  sheath  and  the
wave propagation  of  Ca2+ to  these  cells  occurs  through  gap  junc-
tions, which  leads  to  the  release  of  ATP  by  these  neighboring
satellite glial  cells.  This  ATP  binds  to  the  neuronal  purinergic
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llogeneic  substances  (e.g.,  ATP,  Ca2+)  from  the  site  of  injury
o adjacent  areas,  leading  to  an  ampliﬁcation  of  the  primary
njury.63 Finally,  others  suggest  that  it  will  have  an  action  in
he recycling  of  glutamate.62
ncreased sensitivity to ATP and altered
xpression  of purinergic receptors
everal  studies  reported  the  plasticity  of  P2  receptors
n SGC  in  response  to  nerve  damage  or  inﬂammation,
hich results  in  an  increased  sensitivity  to  ATP  and
ltered expression  of  these  receptors.18,41,74 With  the  use  of
icroﬂuorometry to  determine  the  cytosolic  concentration
f Ca2+,  there  was  an  increased  sensitivity  to  ATP  in  cultured
G of  SGC  of  mice  with  induced  facial  skin  inﬂammation.
imilar results  were  found  in  intact  TG  analysis  in  vitro,  from
ats subjected  to  axotomy  of  the  infraorbital  nerve,  in  which
 100-fold  increase  in  sensitivity  of  SGC  to  ATP  was  recorded.
oreover, the  occurrence  of  a  reversal  in  purinergic  recep-
or subtypes  in  cells  of  TG  culture  can  be  observed  with
he use  of  pharmacological  tools.  In  fact,  in  normal  mice,
he response  to  ATP  was  mediated  by  P2Y  receptors,  while
n mice  with  inﬂammation,  it  was  predominantly  mediated
y P2X.41 Recently,  a  preliminary  model  of  the  SGC  role  in
hronic pain  has  been  proposed  in  an  attempt  to  explain  how
he increased  gap  junctions  and  high  sensitivity  to  ATP  can
ead  to  abnormal  neuronal  activity  both  in  injured  and  non-
njured neurons.  This  model  is  based  on  the  knowledge  that
hen a  peripheral  nerve  injury  increases  the  excitability  of
ensory neurons,  it  also  increases  the  excitatory  signals  from
njured neurons  to  the  SGC  that  surround  them,  and  that
hese cells,  communicating  with  SGC  of  adjacent  units,  will
nﬂuence its  neuron.61 It  also  predicts  that  in  response  to
eripheral injury  a  somatic  ATP  release  occurs,  which  will
ctivate the  P2  receptors  on  the  surrounding  SGC  and  neu-
on itself.  In  turn,  this  activation  should  lead  to  an  increase
n intracellular  Ca2+ in  both  cell  types  and  consequently  ATP
elease from  both  neurons  and  SGC  (whose  level  of  sensitiv-
ty to  Ca2+ increases  after  injury).  This  ATP  increase,  along
ith the  increased  numbers  of  gap  junctions  between  SGC
f neighboring  perineural  sheaths,  will  allow  the  propaga-
ion of  Ca2+ waves  to  these  SGC  and  neighboring  neurons,
nﬂuencing the  excitability  of  neurons  not  directly  affected
y the  lesion  (Figure  2).  This  intraganglionar  communication
odel could  be  one  explanation  of  how  a  peripheral  injury
an affect  a  large  number  of  sensory  neurons,  contributing
o signal  propagation  and  chronic  pain.35,41
roduction of cytokines
GC  have  similar  characteristics  to  cells  of  the  immune  sys-
em, being  activated  by  monocyte  chemotactic  protein-1
MCP-1) through  the  receiver,  and  producing  cytokines  such
s TNF-,23,67 IL-177 and  IL6.78 The  SGC  ability  to  synthesize
NF- in  response  to  a  peripheral  injury  was  shown  in  one
dapted model  of  lumbar  spine  facet  joint  injury  in  mice67
nd  in  three  pain  models  in  sciatic  nerve  (unilateral  par-
ial connection,  spinal  nerve  connection,  and  transaction).
n these  models,  immunocytochemistry  showed  increased
xpression of  TNF-  and  TNF--1  receptor  on  neurons  and
ts SGC.23 Moreover,  it  was  found  that  the  TNF-  activates
m
i
a
oeceptors, inﬂuencing  the  excitability  of  the  neuron  that  was
ot directly  affected  by  the  injury.
he  SGC  causing  increased  phosphorylation  of  protein  kinase
egulated by  extracellular  signals  (ERK79).  Interestingly,  the
ong-term increased  activation  of  this  protein  in  SGC  after
erve injury  has  been  associated  with  chronic  pain.80
Another  cytokine  produced  by  activated  SGC  is  IL-1.  The
ole of  interleukin  in  the  mechanism  underlying  the  devel-
pment of  hyperalgesia  and  allodynia  following  peripheral
nﬂammation has  been  extensively  investigated  in  animal
odels of  cutaneous  inﬂammation.  For  example,  it  was
hown that  SGC  respond  to  this  inﬂammation  with  increased
roduction of  IL-1  and  that  an  increased  expression  of
L-1RI in  neurons  occurs  simultaneously.  It  was  also  shown
hat the  application  of  IL-1  in  neurons  produces  a  greater
ncrease of  the  action  potential  ﬁring  rate  on  inﬂamed
ice compared  to  normal  mice.  Thus,  it  was  postulated
hat SGC  can  modulate  the  excitability  of  TG  nociceptive
eurons via  IL-1,  inducing  membrane  depolarization  and
ncreased expression  of  IL-1RI  in  neuronal  body.77 This
onclusion was  supported  by  a  later  study  with  the  same
odel of  orofacial  pain,  in  which  it  was  observed  that  localontophoretic administration  of  IL-1RI  antagonist  caused
 signiﬁcant  decrease  in  spontaneous  activity  in  neurons
f mice  subjected  to  inﬂammation.81 In  another  study  of
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orofacial  inﬂammatory  pain  in  vitro,  it  was  found  that
IL-1- suppresses  the  K+ currents  of  voltage-dependent
channels  in  small  diameter  neurons  (i.e.,  mostly  A  and
C nociceptive  neurons).  These  data  suggest  that  IL-1-
released by  SGC  activated  after  inﬂammation  potentiates
the excitability  of  nociceptive  neurons  by  suppression  of  K+
currents.82 Gathered  evidence  allowed  the  construction  of  a
mechanism underlying  the  inﬂammatory  hyperalgesia  which
predicts that,  in  inﬂammatory  conditions,  the  activation  of
SGC can  increase  the  excitability  of  A  nociceptive  neurons
via IL-1.  According  to  this  hypothesis,  the  substance  P
released from  the  cell  body  of  primary  afferent  nociceptive
neurons, activated  by  peripheral  injury/inﬂammation,31
will  act  on  NK1  receptors  and  will  somehow  potentiate  the
synthesis and/or  release  of  IL-1  by  SGC.  This  cytokine  will,
in turn,  suppress  the  neuron  voltage-dependent  K+ channels,
thus contributing  to  the  central  sensitization  responsible
for the  hyperalgesia  and  allodynia  after  inﬂammation.22
Finally,  IL-6  also  appears  to  be  involved  in  the  SGC
response to  neuroinﬂammation.  In  fact,  a  bilateral  increased
expression of  IL-6  was  observed  in  SGC  of  DSG  as  well  as  in  its
receptor in  the  ipsilateral  ganglion,  after  sciatic  nerve  injury
by chronic  constriction.78 In  short,  cytokines  are  involved
in the  interaction  between  a  neuron  and  SGC,  and  there  is
growing evidence  of  a  possible  role  for  cytokines  originat-
ing in  sensory  ganglia  in  the  induction  and  maintenance  of
neuropathic pain.83
Final considerations
The  progress  in  understanding  the  SGC  biology,  and  the
recognition of  its  interaction  with  sensory  neurons,  called
the attention  of  the  scientiﬁc  community  to  the  role
of these  cells  in  the  nociceptive  process.  The  perineu-
ronal environment  monitoring  exerted  by  SGC  as  well
as the  cell  communication  occurring  in  sensory  ganglia
(neuron--neuron, neuron--SGC,  SGC--SGC)  can  affect  neu-
ronal excitability.22,35,61 In  fact,  the  changes  resulting  from
the activation  of  SGC,  which  have  been  observed  in  dif-
ferent pain  models,  enabled  the  observation  that  these
cells may  modulate  chronic  pain.16,22,54,63,71 Therefore,  con-
trary to  what  was  initially  postulated,  sensory  ganglion  may
become  the  ﬁrst  level  of  the  pathophysiological  changes  of
modulation of  afferent  signaling,  as  it  allows  the  interaction
between different  types  of  information  and  seems  to  be  a
trigger of  the  central  sensitization  mechanism  of  the  spinal
cord dorsal  horn  neurons.22 Thus,  knowledge  about  the  SGC
and its  mechanisms  of  interaction  with  the  neuronal  body
assumes a  growing  importance  in  the  search  for  new  targets
for chronic  pain  treatment.
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